ImmunityBio IBRX
NASDAQ IBRX
$6.74 -0.37 (-5.13%)
At close: Nov 10, 2026 · 4:00 PM EST

ImmunityBio (IBRX) Total Liabilities (2014 - 2026)

Updated

ImmunityBio's Total Liabilities came in at $1.68 billion for Q2 2026, up 72.4% from $971.9 million a year earlier and up 10.5% from the prior quarter.

Analysis

ImmunityBio (IBRX) Total Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, ImmunityBio's Total Liabilities was $1 billion, up 15.1% from FY2024.

  • Total Liabilities carries a five-year compound annual growth rate of 24.1% (FY2020 to FY2025).
  • Going back by year, Total Liabilities was $871.06 million in FY2024 (-20.1%), $1.09 billion in FY2023 (+34.3%), $812.18 million in FY2022 (+13.9%) and $712.82 million in FY2021 (+109.7%).
  • The Q2 2026 figure represents the highest quarterly Total Liabilities in data going back to Q4 2014.
  • Year-over-year, Total Liabilities has increased for three consecutive quarters, with growth averaging 16.2% over the last eight quarters.
  • The fastest year-over-year change in Total Liabilities over five years came in Q4 2021 (growth of 109.7%), and the weakest in Q4 2024 (a decline of 20.1%).
  • Business Quant data shows IBRX's Total Liabilities at $1.52 billion (Q1 2026), $1 billion (Q4 2025) and $1.04 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 115.90 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 152.26 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 65.46 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 38.37 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 115.70 Bn
10 ImmunityBio 7.48 Bn 6.24 Bn 50.94 Mn 1.68 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.68 Bn
Mar 31, 2026 1.52 Bn
Dec 31, 2025 1.00 Bn
Sep 30, 2025 1.04 Bn
Jun 30, 2025 971.90 Mn
Mar 31, 2025 894.24 Mn
Dec 31, 2024 871.06 Mn
Sep 30, 2024 1.11 Bn
Jun 30, 2024 1.14 Bn
Mar 31, 2024 1.09 Bn
Dec 31, 2023 1.09 Bn
Sep 30, 2023 843.06 Mn
Jun 30, 2023 936.41 Mn
Mar 31, 2023 875.12 Mn
Dec 31, 2022 812.18 Mn
Sep 30, 2022 782.02 Mn
Jun 30, 2022 739.69 Mn
Mar 31, 2022 727.14 Mn
Dec 31, 2021 712.82 Mn
Sep 30, 2021 404.37 Mn
API Access

ImmunityBio Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=IBRX&period=max&api_key=YOUR_API_KEY